User:Goldfinchshuffle/sandbox2

The Medical Technologies Advisory Committee (MTAC)
The Medical Technologies Advisory Committee (MTAC) is a UK independent committee behind the UK's National Institute for Health and Clinical Excellence (NICE) Medical Technologies Evaluation Programme (MTEP). MTAC reviews novel devices and diagnostics with plausible claims for advantages to patients and/or to the NHS, selected for evaluation by MTEP.

MTAC meets monthly and is open to members of the general public.

Members receive papers 2 weeks before the meeting which include an overview, highlighting the key issues and uncertainties in the companies submission and assessment report.

The aim of MTEP is to identify novel devices and diagnostics with plausible claims for advantages to patients and/or to the NHS. If evaluation supports the claims made by manufacturers for their products then their use will be promoted by NICE guidance. Typically, medical technologies guidance will state that ‘the case for adoption is supported by the evidence’ and specify the advantages and the cost savings of adopting the product, compared with current management. The guidance may also recommend specified research and the programme has capacity to foster research into promising technologies. The aim is to provide guidance relatively quickly—ideally for novel devices and diagnostics that offer a ‘step-change’ in management.